Home MSJ

MSJ

In operation
Series B
Recombinant Gene Editing Technology Researcher
Basic
Enterprise Profile

Basic Information

MSJ Biotech Co., Ltd. has achieved remarkable results in the field of gene editing with its forward-looking R&D concepts and leading technical strength. The company's unique recombinant gene editing technology ingeniously combines recombinant collagen protein with recombinant fibronectin, forming a distinctive microcapsule model. This technology not only ensures the bioactivity of collagen but also enhances its permeability and stability in the skin. MSJ has developed this technology into a comprehensive technical platform, which has the potential to develop proteins needed for various parts of the human body.
MSJ
Jiangsu,China
15~50 people
July 19, 2021
--
kenzhaogutai@163.com

Enterprise Profile

Industrial Sector
Biomanufacturing Medical Consumables Manufacturing Surgical Dressing Production
Technology
Gene Editing
Concept
Plastic Surgery Dermatology Department Skin Diseases
Application Scenarios
Medical Aesthetics Recombinant Protein Medical Device Consumables